Study to Test the Efficacy and Safety of Padsevonil as Adjunctive Treatment of Focal-onset Seizures in Adults With Drug-resistant Epilepsy

NCT03373383 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

411

Enrollment

INDUSTRY

Sponsor class

Conditions

Drug-resistant Epilepsy
Focal-Onset Seizures

Interventions

DRUG: Padsevonil
OTHER: Placebo

Sponsor

UCB Biopharma S.P.R.L.